Elevated Serum Levels of Interleukin-17A in Uveitis Patients

References

• Marwaha AK, Leung NJ, McMurchy AN, Levings MK. TH17 cells in autoimmunity and immunodeficiency: protective or pathogenic? Frontiers Immunol. 2012;3:129
   PubMed Web of Science ®Google Scholar
• Bending D, Newland S, Krejci A, et al. Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behavior of Th17 cells. J Immunol. 2011;186:3373–3382
   PubMed Web of Science ®Google Scholar
• Gaffen SL. An overview of IL-17 function and signaling. Cytokine. 2008;43:402–407
   PubMed Web of Science ®Google Scholar
• Caspi R. Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells. Immunol Res. 2008;42:41–50
   PubMed Web of Science ®Google Scholar
• Luger D, Caspi RR. New perspectives on effector mechanisms in uveitis. Semin Immunopathol. 2008;30:135–143
   PubMed Web of Science ®Google Scholar
• Li J, Chen X, Liu Z, et al. Expression of Th17 cytokines in skin lesions of patients with psoriasis. J Huazhong U Sci-Med. 2007;27:330–332
   PubMedGoogle Scholar
• Cascao R, Moura RA, Perpetuo I, et al. Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis. Arthritis Res Therapy. 2010;12:R196
   PubMedGoogle Scholar
• Wong CK, Lit LC, Tam LS, et al. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol. 2008;127:385–393
   PubMed Web of Science ®Google Scholar
• Mei Y, Pan F, Gao J, et al. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin Rheumatol. 2011;30:269–273
   PubMed Web of Science ®Google Scholar
• Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2003;52:65–70
   PubMed Web of Science ®Google Scholar
• Amadi-Obi A, Yu CR, Liu X, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nature Med. 2007;13:711–718
   PubMed Web of Science ®Google Scholar
• Chen Y, Yang P, Li F, Kijlstra A. The effects of Th17 cytokines on the inflammatory mediator production and barrier function of ARPE-19 cells. PloS One. 2011;6:e18139
   Google Scholar
• Hamzaoui K, Bouali E, Ghorbel I, et al. Expression of Th-17 and RORgammat mRNA in Behçet's disease. Med Sci Monitor. 2011;17:CR227–CR234
   PubMed Web of Science ®Google Scholar
• Chi W, Zhu X, Yang P, et al. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Visual Sci. 2008;49:3058–3064
   PubMed Web of Science ®Google Scholar
• Chi W, Yang P, Li B, et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol. 2007;119:1218–1224
   PubMed Web of Science ®Google Scholar
• Kuiper JJ, Mutis T, de Jager W, et al. Intraocular interleukin-17 and proinflammatory cytokines in HLA-A29-associated birdshot chorioretinopathy. Am J Ophthalmol. 2011;152:177–182 e171
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516
   PubMed Web of Science ®Google Scholar
• Herbort CP, Rao NA, Mochizuki M, members of Scientific Committee of First International Workshop on Ocular S. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17:160–169
   PubMed Web of Science ®Google Scholar
• Thompson IA, Liu B, Sen HN, et al. Association of complement factor h tyrosine 402 histidine genotype with posterior involvement in sarcoid-related uveitis. Am J Ophthalmol. 2013;155:1068–1074 e1061
   PubMed Web of Science ®Google Scholar
• International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet. 1990;335:1078–1080
   PubMed Web of Science ®Google Scholar
• The International Study Group for Behçet's Disease. Evaluation of diagnostic (‘classification') criteria in Behçet's disease—towards internationally agreed criteria. Br J Rheumatol. 1992;31:299–308
   PubMedGoogle Scholar
• Behçet's Disease Research Committee. Clinical research section recommendations. Jpn J Ophthalmol. 1974;18:291–294
   Google Scholar
• Furusato E, Shen D, Cao X, et al. Inflammatory cytokine and chemokine expression in sympathetic ophthalmia: a pilot study. Histol Histopathol. 2011;26:1145–1151
   PubMed Web of Science ®Google Scholar
• Wendling D, Toussirot E. Bone and matrix remodeling markers: a new tool for assessment of treatment efficacy in ankylosing spondylitis? J Rheumatol. 2007;34:1647–1649
   Google Scholar
• Chen WS, Chang YS, Lin KC, et al. Association of serum interleukin-17 and interleukin-23 levels with disease activity in Chinese patients with ankylosing spondylitis. J Chin Med Assoc. 2012;75:303–308
   PubMed Web of Science ®Google Scholar
• Metawi SA, Abbas D, Kamal MM, Ibrahim MK. Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clin Rheumatol. 2011;30:1201–1207
   PubMed Web of Science ®Google Scholar
• Hamzaoui K, Hamzaoui A, Guemira F, et al. Cytokine profile in Behçet's disease patients: relationship with disease activity. Scand J Rheumatol. 2002;31:205–210
   PubMed Web of Science ®Google Scholar
• Londono J, Romero-Sanchez MC, Torres VG, et al. The association between serum levels of potential biomarkers with the presence of factors related to the clinical activity and poor prognosis in spondyloarthritis. Rev Bras Reumatol. 2012;52:536–544
   Google Scholar
• Sugita S, Horie S, Yamada Y, et al. Suppression of interleukin-17-producing T-helper 17 cells by retinal pigment epithelial cells. Jpn J Ophthalmol. 2011;55:565–575
   Google Scholar
• Chi W, Yang P, Zhu X, et al. Production of interleukin-17 in Behçet's disease is inhibited by cyclosporin A. Mol Vision. 2010;16:880–886
   PubMed Web of Science ®Google Scholar
• Hueber W, Patel DD, Dryja T, et al. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med. 2010;2:52ra72
   PubMed Web of Science ®Google Scholar
• Dick AD, Tugal-Tutkun I, Foster S, et al. Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials. Ophthalmology. 2013;120:777–787
   PubMed Web of Science ®Google Scholar
• Kang MH, Kim MK, Lee HJ, et al. Interleukin-17 in various ocular surface inflammatory diseases. J Korean Med Sci. 2011;26:938–944
   PubMed Web of Science ®Google Scholar